|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, close to half of total revenue is generated within the United States.
JNJ $136.91 -1.19 (-0.86%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 366.37 Billion
EPS 1.13 P/E Ratio 24.40
Previous Earnings Tue, Oct 16, 2018
Latest Earnings Tue, Jan 22, 2019
Dividend 2.63% / $3.60
Ex-Date Mon, Feb 25, 2019
Dividend Pay Date Tue, Mar 12, 2019
Dividend History 189 Payments (Quarterly)
Investing Quotes #Legendary
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.